Neisseria meningitidis, Serogroup B
"Neisseria meningitidis, Serogroup B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Strains of Neisseria meningitidis which are the most common ones causing infections or disease in infants. Serogroup B strains are isolated most frequently in sporadic cases, and are less common in outbreaks and epidemics.
Below are MeSH descriptors whose meaning is more general than "Neisseria meningitidis, Serogroup B".
Below are MeSH descriptors whose meaning is more specific than "Neisseria meningitidis, Serogroup B".
This graph shows the total number of publications written about "Neisseria meningitidis, Serogroup B" by people in Harvard Catalyst Profiles by year, and whether "Neisseria meningitidis, Serogroup B" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
Below are the most recent publications written about "Neisseria meningitidis, Serogroup B" by people in Profiles.
Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits. Front Public Health. 2020; 8:261.
Vaccines and global health: In search of a sustainable model for vaccine development and delivery. Sci Transl Med. 2019 06 19; 11(497).
Immunization with Outer Membrane Vesicles Displaying Designer Glycotopes Yields Class-Switched, Glycan-Specific Antibodies. Cell Chem Biol. 2016 06 23; 23(6):655-65.
The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects. Future Microbiol. 2015; 10(10):1579-98.
Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015. MMWR Morb Mortal Wkly Rep. 2015 Jun 12; 64(22):606-7.
Neisseria meningitidis subverts the polarized organization and intracellular trafficking of host cells to cross the epithelial barrier. Cell Microbiol. 2015 Sep; 17(9):1365-75.
Protectome analysis: a new selective bioinformatics tool for bacterial vaccine candidate discovery. Mol Cell Proteomics. 2015 Feb; 14(2):418-29.
Immunisation against meningococcus B. Lancet. 2013 Sep 07; 382(9895):857.
LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression. Innate Immun. 2012 Aug; 18(4):580-91.
Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival. PLoS Pathog. 2011 May; 7(5):e1002027.